Your browser doesn't support javascript.
loading
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Alzahrani, Musa; Power, Maryse; Abou Mourad, Yasser; Barnett, Michael; Broady, Raewyn; Forrest, Donna; Gerrie, Alina; Hogge, Donna; Nantel, Stephen; Sanford, David; Song, Kevin; Sutherland, Heather; Toze, Cynthia; Nevill, Thomas; Narayanan, Sujaatha.
Affiliation
  • Alzahrani M; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; King Saud University, Riyadh, Saudi Arabia.
  • Power M; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Abou Mourad Y; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Barnett M; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Broady R; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Forrest D; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Gerrie A; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Hogge D; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Nantel S; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Sanford D; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Song K; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Sutherland H; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Toze C; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Nevill T; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Narayanan S; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, BC Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: snarayanan@bccancer.bc.ca.
Biol Blood Marrow Transplant ; 24(6): 1209-1215, 2018 06.
Article in En | MEDLINE | ID: mdl-29474870

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prognosis / Myelodysplastic Syndromes / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2018 Type: Article Affiliation country: Saudi Arabia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prognosis / Myelodysplastic Syndromes / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2018 Type: Article Affiliation country: Saudi Arabia